Cite
HARVARD Citation
Guerenne, L. et al. (2016). GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. Journal of hematology & oncology. 9 (1), pp. 1-20. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guerenne, L. et al. (2016). GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. Journal of hematology & oncology. 9 (1), pp. 1-20. [Online].